Clinical efficacy of Ayurveda and Yoga treatment regimen on sub fertility with Poly Cystic Ovarian Syndrome (PCOS)

Banaras Hindu University0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年5月2日

试验速览

暂无简介。

•Patients of female infertility who satisfied the Rotterdam criterion (2/3 of the features) for PCOS
•1-Oligo/amenorrhea: Absence of menstruation for 45 days or more and/or less than eight menses per year.
•2-Clinical hyperandrogenism, Modified Ferriman and Gallway (mFG) score of 6 or higher. Biochemical hyperandrogenism, serum LH and FSH ratio more than 2:1
•3-Poly cystic ovaries: Presence of >10 cysts, 2-8 mm in diameter, usually combined with increased ovarian volume of >10 cm3, and an echo-dense stroma in pelvic ultrasound scan.

•1-Patients who use of oral contraceptives/hormone treatment/insulin-sensitizing agents within previous six weeks.
•2-Patients who have addiction of alcohol,smoking and any prior experience of yoga
•3-Patients who have Hyperprolactinemia, thyroid abnormalities and non-classic adrenal hyperplasia, and those who did not consent for the study.
•4-Patients who have Primary ammenorheoa, Premature ovarian failure, absent ovary and uterus.
•5-The patients suffering from diabetes mellitus, hypertension, thyroid disorders, hyper prolactinemia, congenital adrenal hyperplasia, other gynaecological disorders, and renal failure
•6-Patients with evidence of malignancy
•7-Patients suffering from major systemic illness necessitating long term drug treatment (Rheumatoid arthritis, Psycho-Neuro-Endocrinal disorders, etc.)
•8-Patients who have a past history of Atrial Fibrillation, Coronary Artery Disease (CAD), Acute Coronary Syndrome, Myocardial Infarction, Stroke or Severe Arrhythmia in the last 6 months.
•9-Symptomatic patient with clinical evidence of Heart failure.
•10-Patients on prolonged ( > 6 weeks) medication with corticosteoids, antidepressants, anticholinergics, etc. or any other drugs that may have an influence on the outcome of the study.
•11-Patients who have completed participation in any other clinical trial during the past six (06) months.
•12-Any other condition which the Principal Investigator thinks may jeopardize the study
•Study Duration : 6 months

发起方